Lineage Cell Therapeutics LCTX
NYSE LCTX
$0.98 +0.03 (+3.16%)
At close: Oct 22, 2026 · 4:00 PM EDT

Lineage Cell Therapeutics (LCTX) Shares Repurchased (2021 - 2022)

Updated

Analysis

Lineage Cell Therapeutics (LCTX) Shares Repurchased (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 1.60 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 1.71 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 9.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 757.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 1.20 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 355.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Lineage Cell Therapeutics 247.85 Mn 46.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 11,000.00
Sep 30, 2022 38,000.00
Dec 31, 2021 121,000.00
Sep 30, 2021 103,000.00
Jun 30, 2021 263,000.00
Mar 31, 2021 614,000.00
API Access

Lineage Cell Therapeutics Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=LCTX&period=max&api_key=YOUR_API_KEY